Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Updates in Surgery|March 17, 2022
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experienceMassimiliano Tuveri, Claudio Bassi, Alessandro Esposito, et al.
British Journal of Cancer|January 18, 2022
Development and external validation of a prediction model for overall survival after resection of distal cholangiocarcinomaAli Belkouz, Stijn Van Roessel, Marin Strijker, et al.
Annals of Surgery|June 23, 2025
Robot-assisted and Laparoscopic Extended Left Pancreatectomy: A Pan-European Multicenter Propensity-score Matched AnalysisCaro L Bruna, Tess van Ramshorst, Jony van Hilst, et al.
International Journal of Cancer|July 25, 2019
Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinomaMarin Strijker, Eline C Soer, Matteo de Pastena, et al.
Surgical Endoscopy|November 20, 2021
Performance with robotic surgery versus 3D- and 2D-laparoscopy during pancreatic and biliary anastomoses in a biotissue model: pooled analysis of two randomized trialsMaurice J W Zwart, Leia R Jones, Ignacio Fuente, et al.
Annals of Surgery|July 7, 2022
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International ValidationMatteo De Pastena, Eduard A van Bodegraven, Timothy H Mungroop, et al.
Annals of Surgery|August 1, 2024
Interobserver Variability in the International Study Group for Pancreatic Surgery (ISGPS)-Defined Complications After Pancreatoduodenectomy: An International Cross-Sectional Multicenter StudyTessa E Hendriks, Alberto Balduzzi, Susan van Dieren, et al.
The Lancet. Gastroenterology & Hepatology|March 18, 2024
Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trialEduard A van Bodegraven, Alberto Balduzzi, Tess M E van Ramshorst, et al.
Annals of Surgical Oncology|December 20, 2022
Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort StudyEran van Veldhuisen, Sjors Klompmaker, Quisette P Janssen, et al.
JAMA Oncology|September 10, 2020
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX TreatmentStijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker, et al.
Pageof 4